Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether lower than conventional doses of
dexamethasone and thalidomide; and a higher dosing frequency of zoledronic acid are effective
in the treatment of newly-diagnosed multiple myeloma.
Phase:
Phase 2
Details
Lead Sponsor:
Gleneagles Hospital
Collaborators:
Asan Medical Center Chonnam National University Hospital Christian Medical College, Vellore, India National Cancer Centre, Singapore Samsung Medical Center Seoul National University Hospital Singapore General Hospital Tan Tock Seng Hospital Tata Memorial Hospital